See more : Feedback plc (FDBK.L) Income Statement Analysis – Financial Results
Complete financial analysis of Zelira Therapeutics Limited (ZLD.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zelira Therapeutics Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Mymetics Corporation (MYMX) Income Statement Analysis – Financial Results
- Pioneer Power Solutions, Inc. (PPSI) Income Statement Analysis – Financial Results
- Nozaki Insatsu Shigyo Co., Ltd. (7919.T) Income Statement Analysis – Financial Results
- RCL Foods Limited (RCL.JO) Income Statement Analysis – Financial Results
- Wuxi Taiji Industry Limited Corporation (600667.SS) Income Statement Analysis – Financial Results
Zelira Therapeutics Limited (ZLD.AX)
About Zelira Therapeutics Limited
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and diabetes. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent's Hospital; and the Children's Hospital of Philadelphia. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94.95K | 301.12K | 1.54M | 663.32K | 0.00 | 769.03K | 313.76K | 100.04K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.25K | 0.00 | 0.00 | 21.08M | 140.69K | 569.48K | 501.04K |
| Cost of Revenue | 84.67K | 3.52M | 7.26M | 702.48K | 275.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.85M | 70.66K | 178.19K | 141.29K |
| Gross Profit | 10.28K | -3.22M | -5.72M | -39.16K | -275.05K | 769.03K | 313.76K | 100.04K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.25K | 0.00 | 0.00 | 24.93M | 70.03K | 391.29K | 359.75K |
| Gross Profit Ratio | 10.83% | -1,068.03% | -371.02% | -5.90% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 118.25% | 49.78% | 68.71% | 71.80% |
| Research & Development | 2.81M | 1.34M | 1.40M | 2.08M | 3.69M | 2.33M | 1.79M | 668.41K | 14.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.34M | 5.64M | 6.59M | 5.28M | 1.97M | 1.25M | 397.37K | 1.35M | 456.94K | 207.75K | 180.00K | 214.56K | 443.35K | 242.51K | 490.56K | 507.34K | 59.75K | 1.20M | 675.35K | 372.46K | 245.36K |
| Selling & Marketing | 0.00 | 74.59K | 715.24K | 510.07K | 923.74K | 586.63K | 153.13K | 1.05M | 63.25K | 83.84K | 67.65K | 84.80K | 123.57K | 126.28K | 490.52K | 365.25K | 187.33K | 333.39K | 62.53K | 46.07K | 60.51K |
| SG&A | 1.34M | 2.59M | 6.30M | 7.53M | 3.87M | 1.90M | 1.02M | 1.90M | 456.94K | 207.75K | 180.00K | 214.56K | 443.35K | 242.51K | 490.56K | 507.34K | 59.75K | 1.20M | 675.35K | 372.46K | 245.36K |
| Other Expenses | 1.80M | -266.52K | 1.28M | 1.48M | 925.49K | 580.44K | 959.82K | 99.34K | -24.95K | 12.16K | -15.78K | -18.92K | -36.03K | 440.67K | -201.19K | 177.42K | -211.08K | -1.51M | -99.53K | 45.46K | 522.50K |
| Operating Expenses | 5.95M | 4.20M | 7.70M | 9.61M | 7.56M | 4.23M | 2.82M | 2.57M | 876.42K | 423.83K | 295.18K | 322.06K | 630.63K | 463.08K | 1.15M | 1.85M | 487.99K | 46.55M | 1.35M | 860.64K | 1.04M |
| Cost & Expenses | 6.27M | 7.71M | 14.96M | 10.32M | 7.84M | 4.23M | 2.82M | 2.57M | 876.42K | 423.83K | 295.18K | 322.06K | 630.63K | 463.08K | 1.15M | 1.85M | 487.99K | 42.70M | 1.48M | 1.04M | 1.18M |
| Interest Income | 309.00 | 134.00 | 10.60K | 723.00 | 8.60K | 90.14K | 138.57K | 67.72K | 2.73K | 11.59K | 20.74K | 29.13K | 28.70K | 29.44K | 58.77K | 129.43K | 22.62K | 64.67K | 95.38K | 117.06K | 129.78K |
| Interest Expense | 739.27K | 76.66K | 53.85K | 42.63K | 12.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.25K | 0.00 | 102.20K | 203.13K | 4.83K | 16.00 |
| Depreciation & Amortization | 479.04K | 545.22K | 588.54K | 474.26K | 275.05K | 3.32M | 2.37M | 2.44M | 161.10K | 0.00 | 336.00 | 5.22K | 13.95K | 11.54K | 16.97K | 16.81K | 0.00 | 3.15M | 62.05K | 72.28K | 27.02K |
| EBITDA | -36.44M | -6.87M | -12.83M | -9.18M | -7.71M | -251.28K | 635.41K | -3.71M | -898.64K | -423.83K | -289.88K | -306.63K | -624.00K | 18.57K | -1.10M | -20.22M | -487.99K | -34.89M | -1.22M | -402.82K | 1.45K |
| EBITDA Ratio | -38,378.53% | -2,280.68% | -832.55% | -1,383.63% | 0.00% | -549.65% | -897.39% | -2,569.26% | -292.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,955.02% | 0.00% | 0.00% | -94.60% | -867.45% | -41.19% | 0.29% |
| Operating Income | -5.94M | -7.41M | -13.41M | -9.65M | -7.84M | -4.23M | -2.82M | -2.57M | -876.42K | -423.83K | -295.18K | -322.06K | -630.63K | -463.08K | -1.12M | -1.85M | -487.99K | -21.62M | -1.27M | -469.35K | -677.84K |
| Operating Income Ratio | -6,253.93% | -2,461.74% | -870.75% | -1,455.13% | 0.00% | -549.65% | -897.39% | -2,569.26% | -292.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,258.59% | 0.00% | 0.00% | -102.58% | -900.08% | -82.42% | -135.29% |
| Total Other Income/Expenses | -31.72M | -148.40K | -290.82K | -275.31K | 725.95K | -251.28K | 635.41K | -3.69M | -248.32K | -82.12K | 4.96K | 10.22K | -7.33K | 470.11K | -571.93K | -18.42M | 22.62K | -16.54M | -219.27K | -10.58K | 652.26K |
| Income Before Tax | -37.66M | -7.41M | -13.71M | -9.93M | -8.00M | -4.34M | -2.04M | -6.26M | -898.64K | -400.08K | -290.22K | -311.84K | -637.96K | 7.03K | -1.69M | -20.27M | -465.37K | -38.16M | -1.49M | -311.67K | -25.58K |
| Income Before Tax Ratio | -39,661.61% | -2,461.31% | -889.62% | -1,496.64% | 0.00% | -563.94% | -651.32% | -6,254.83% | -299.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4,928.45% | 0.00% | 0.00% | -181.04% | -1,055.93% | -54.73% | -5.10% |
| Income Tax Expense | -919.74K | -1.14M | -1.29M | -1.38M | -981.78K | -769.03K | -313.76K | -100.04K | -163.83K | 0.00 | -20.74K | -29.13K | -28.70K | -29.44K | 370.74K | 211.67K | -13.08M | -1.41M | -584.27K | -311.67K | -25.58K |
| Net Income | -36.57M | -5.57M | -11.95M | -8.55M | -7.02M | -3.57M | -1.73M | -6.16M | -898.64K | -400.08K | -290.22K | -311.84K | -637.96K | 7.03K | -1.69M | -20.27M | 12.61M | -38.16M | -901.34K | -311.67K | 0.00 |
| Net Income Ratio | -38,513.04% | -1,850.75% | -775.35% | -1,288.84% | 0.00% | -463.94% | -551.32% | -6,154.83% | -299.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4,928.45% | 0.00% | 0.00% | -181.04% | -640.65% | -54.73% | 0.00% |
| EPS | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 | -0.40 | -2.18 | -1.39 | -0.73 | -0.53 | -0.57 | -1.99 | 0.02 | -5.03 | -116.56 | 464.49 | -15.47K | -413.08 | -240.67 | -22.65 |
| EPS Diluted | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 | -0.40 | -2.18 | -1.39 | -0.73 | -0.53 | -0.57 | -1.99 | 0.02 | -5.03 | -116.56 | 464.49 | -15.47K | -413.08 | -240.67 | -22.65 |
| Weighted Avg Shares Out | 11.35M | 10.07M | 8.04M | 6.63M | 4.85M | 4.31M | 4.31M | 2.83M | 646.55K | 551.24K | 551.24K | 551.24K | 320.42K | 335.85K | 335.86K | 173.91K | 27.16K | 2.47K | 2.18K | 1.30K | 1.09K |
| Weighted Avg Shares Out (Dil) | 11.35M | 10.07M | 8.04M | 6.63M | 4.85M | 4.31M | 4.31M | 2.83M | 646.55K | 551.24K | 551.24K | 551.24K | 320.42K | 335.85K | 335.86K | 173.91K | 27.16K | 2.47K | 2.18K | 1.30K | 1.09K |
Source: https://incomestatements.info
Category: Stock Reports